Vertaling van "patients using a generic " (Nederlands → Frans) :

In order to ensure that the patientÊs perspective is represented, it is crucial that the health states are first described by the patients, using a generic descriptive system for healthrelated quality of life (e.g. the EQ-5D, the SF-36).
In order to ensure that the patientÊs perspective is represented, it is crucial that the health states are first described by the patients, using a generic descriptive system for health-related quality of life (e.g. the EQ-5D, the SF-36).

In the US (+4%), Diovan increased its leadership of the ARB segment despite the overall shrinking of the branded anti-hypertension market due to increasing use of generic medicines in other anti-hypertensive classes.
Aux Etats-Unis (+4%), Diovan a augmenté son leadership dans le segment des ARA en dépit de la contraction générale du marché des produits de marque contre l’hypertension en raison de l’utilisation accrue de médicaments génériques dans d’autres classes d’hypotenseurs.

In the US, Diovan (+3%) expanded during the 2009 nine-month period despite greater use of generic versions of high blood pressure medicines in other classes.
Aux Etats-Unis, Diovan (+3%) a poursuivi sa progression au cours des neuf premiers mois de l’année malgré une utilisation accrue des versions génériques d’hypotenseurs d’autres catégories.

There are disease specific and generic health-related quality of life measures, profile measures or single index measures, health-related quality of life can be assessed by patients themselves or by health care providers or family and valuation of a health state can be done by means of a Time-Trade-Off, Standard Gamble or Rating Scale.
There are disease specific and generic health-related quality of life measures, profile measures or single index measures, health-related quality of life can be assessed by patients themselves or by health care providers or family and valuation of a health state can be done by means of a Time- Trade-Off, Standard Gamble or Rating Scale.

Delivering innovation, growth and productivity Novartis continues to advance its strategy to meet the needs of patients everywhere with a broad healthcare portfolio that includes innovative medicines, preventive vaccines, cost-effective generics and self-care products.
Promouvoir l'innovation, la croissance et la productivité Novartis continue de développer sa stratégie pour répondre aux besoins des malades où qu’ils soient avec un vaste portefeuille de soins de santé qui comprend des médicaments innovants, des vaccins préventifs, des génériques peu coûteux et des produits d’automédication.

Reclast/Aclasta (USD 325 million, +100% lc), the first once-yearly infusion therapy for osteoporosis, continues to expand on increasing patient access to infusion centers and a broad range of use in patients suffering from various types of this debilitating disease.
Aclasta/Reclast (USD 325 millions, +100% en m. l.), le premier traitement de l’ostéoporose par perfusion annuelle, poursuit sa croissance en facilitant l’accès des malades aux centres de perfusion ainsi qu’en allongeant la liste des indications autorisées pour une utilisation chez les patients souffrant de différents types de cette maladie invalidante.

Trials are also underway examining the use of Tasigna in CML patients with suboptimal response to Glivec and in patients with metastatic GIST.
Des essais sont aussi en cours pour étudier l’utilisation de Tasigna dans la LMC chez des malades qui répondent mal au Glivec ainsi que chez malades atteints de GIST métastasique.

Trials are also underway examining the use of Tasigna in CML patients with suboptimal response to Glivec and in patients with metastatic and/or unresectable Kit+ GIST.
Des essais sont aussi en cours pour étudier l’utilisation de Tasigna dans la LMC chez des malades qui répondent mal au Glivec ainsi que chez des malades atteints de GIST métastasique et/ou à Kit+ non résectable.

occasional use of glyceryl trinitrate (GTN)spray (two to three times per month).Does not include patients with unstable angina who would be ASA grade.
occasional use of glyceryl trinitrate (GTN)spray (two to three times per month). Does not include patients with unstable angina who would be ASA grade.

use of cerebral protection during carotid artery stenting: results of a multicenter registry of 753 patients.
33. Reimers B, Schluter M, Castriota F, Tubler T, Corvaja N, Cernetti C, et al. Routine use of cerebral protection during carotid artery stenting: results of a multicenter registry of 753 patients.